Therapeutics(LENZ)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

LENZ Therapeutics

休市中 12-26 16:00:00 EST

16.87

-0.27

-1.58%

盘后17.01

+0.14+0.83%

19:50 EST

最高17.06	最低16.49	成交量53.66万
今开17.02	昨收17.14	日振幅3.35%
总市值5.28亿	流通市值2.65亿	总股本3,129万
成交额902.56万	换手率3.42%	流通股本1,569万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"LENZ","market":"US","secType":"STK","nameCN":"Therapeutics","latestPrice":16.87,"timestamp":1766782800000,"preClose":17.14,"halted":0,"volume":536578,"hourTrading":{"tag":"盘后","latestPrice":17.01,"preClose":16.87,"latestTime":"19:50 EST","volume":15751,"amount":265703.2671,"timestamp":1766796623273},"delay":0,"floatShares":15692500,"shares":31289969,"eps":-1.898372,"marketStatus":"休市中","change":-0.27,"latestTime":"12-26 16:00:00 EST","open":17.02,"high":17.06,"low":16.485,"amount":9025621.320646,"amplitude":0.033547,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.898372,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1766998800000},"marketStatusCode":7,"adr":0,"listingDate":1624593600000,"exchange":"NASDAQ","adjPreClose":17.14,"preHourTrading":{"tag":"盘前","latestPrice":17.09,"preClose":17.14,"latestTime":"09:25 EST","volume":1526,"amount":26197.641624,"timestamp":1766759110041},"postHourTrading":{"tag":"盘后","latestPrice":17.01,"preClose":16.87,"latestTime":"19:50 EST","volume":15751,"amount":265703.2671,"timestamp":1766796623273},"volumeRatio":0.7337720466224203,"impliedVol":1.1595,"impliedVolPercentile":0.9448},"requestUrl":"/m/hq/s/LENZ","defaultTab":"news","newsList":[{"id":"2594294036","title":"Quince Therapeutics, Inc.盘中异动 早盘股价大跌5.05%报3.48美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2594294036","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2594294036?lang=zh_cn&edition=full","pubTime":"2025-12-26 22:52","pubTimestamp":1766760723,"startTime":"0","endTime":"0","summary":"北京时间2025年12月26日22时52分，Quince Therapeutics, Inc.股票出现异动，股价急速跳水5.05%。Quince Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.22%。Quince Therapeutics, Inc.公司简介：Quince Therapeutics Inc 是一家临床前阶段的生物制药公司，专注于推进针对衰弱和罕见疾病的精准治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251226225204a6d31f8e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251226225204a6d31f8e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4007","LENZ","BK4139","QNCX"],"gpt_icon":0},{"id":"2593734104","title":"2026美股生物科技板块怎么投资？杰富瑞：关注这6大首选股、7大潜力标的和5大并购目标","url":"https://stock-news.laohu8.com/highlight/detail?id=2593734104","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593734104?lang=zh_cn&edition=full","pubTime":"2025-12-25 06:00","pubTimestamp":1766613621,"startTime":"0","endTime":"0","summary":"杰富瑞近日发布了关于2026年美股生物科技行业的展望报告，聚焦行业首选投资标的、被低估的潜力企业和潜在并购机会。","market":"sh","thumbnail":"https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1385521.html","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":"2026美股生物科技板块怎么投资？杰富瑞：关注这6大首选股、7大潜力标的和5大并购目标","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["TNGX","LENZ","ORIC","TYRA","SLDB","TSHA"],"gpt_icon":0},{"id":"2594289326","title":"Inhibikase Therapeutics, Inc.盘中异动 大幅拉升5.97%报1.69美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2594289326","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2594289326?lang=zh_cn&edition=full","pubTime":"2025-12-25 01:46","pubTimestamp":1766598388,"startTime":"0","endTime":"0","summary":"北京时间2025年12月25日01时46分，Inhibikase Therapeutics, Inc.股票出现波动，股价快速上涨5.97%。Inhibikase Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.05%。Inhibikase Therapeutics, Inc.公司简介：Inhibikase Therapeutics Inc 是一家临床阶段制药公司，致力于开发蛋白激酶抑制剂疗法，以改变帕金森病，帕金森病相关疾病和其他 Abelson 酪氨酸激酶疾病的病程。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025122501462897a0a77d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025122501462897a0a77d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IKT","LENZ","BK4139","BK4007","BK4539"],"gpt_icon":0},{"id":"2594282908","title":"Whitehawk Therapeutics, Inc.盘中异动 大幅上涨5.28%报2.79美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2594282908","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2594282908?lang=zh_cn&edition=full","pubTime":"2025-12-24 23:20","pubTimestamp":1766589646,"startTime":"0","endTime":"0","summary":"北京时间2025年12月24日23时20分，Whitehawk Therapeutics, Inc.股票出现异动，股价快速上涨5.28%。Whitehawk Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.49%。其相关个股中，奥麦罗制药、Indaptus Therapeutics, Inc.、Dermata Therapeutics Inc C/Wts 涨幅较大，Dermata Therapeutics, Inc.、Indaptus Therapeutics, Inc.、Citius Pharmaceuticals, Inc.较为活跃，换手率分别为1766.77%、1194.23%、59.51%，振幅较大的相关个股有Briacell Therapeutics Corp C/Wts 26/02/2026、Citius Pharmaceuticals, Inc.、Indaptus Therapeutics, Inc.，振幅分别为62.58%、52.88%、32.82%。Whitehawk Therapeutics, Inc.公司简介：Whitehawk Therapeutics Inc 是一种临床前阶段的肿瘤治疗药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251224232047953b9d96&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251224232047953b9d96&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4539","WHWK","BK4139","LENZ"],"gpt_icon":0},{"id":"2593047013","title":"美股异动 | 与吉利德科学(GILD.US)达成出售实验性抗癌资产协议 Repare Therapeutics(RPTX.US)盘前一度大涨约20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2593047013","media":"智通财经网","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593047013?lang=zh_cn&edition=full","pubTime":"2025-12-24 22:19","pubTimestamp":1766585945,"startTime":"0","endTime":"0","summary":"该公司已与吉利德科学达成资产购买协议，收购其实验性抗癌疗法RP-3467，交易总价值最高可达3000万美元","market":"fut","thumbnail":"https://img.zhitongcaijing.com/image/20251224/20251224222230_71916.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/image/20251224/20251224222230_71916.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"09853388b565e5412a3d944672ba7d17","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1385682.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK4539","SG9999015978.USD","IE00B3T34201.USD","IE00BKVL7J92.USD","IE00BZ1G4Q59.USD","LU2089984988.USD","BK4568","BK4139","BK4585","LU1674673691.USD","GILD","IE00B19Z3B42.SGD","BK4007","LU2468319806.SGD","LU1571399168.USD","LU1066051498.USD","LENZ","LU0823416689.USD","LU0289739699.SGD","BK4588","LU0320765992.SGD","SG9999015986.USD","IE00B7SZLL34.SGD","LU2324357040.USD","LU0058720904.USD","BK4532","LU0234570918.USD","LU1839511570.USD","LU1585245621.USD","IE00BSNM7G36.USD","RPTX","BK4578","IE0002270589.USD","LU2087621335.USD","LU1778281490.HKD","LU0114720955.EUR","BK4583","LU0889565916.HKD","LU1066053197.SGD","IE00B19Z3581.USD","BK4566","SG9999015945.SGD","SG9999015952.SGD","LU0882574055.USD","LU1674673428.USD","LU0109394709.USD","BK4550","LU1430594728.SGD"],"gpt_icon":0},{"id":"2593444029","title":"基因治疗公司Frontera Therapeutics-B  递表港交所","url":"https://stock-news.laohu8.com/highlight/detail?id=2593444029","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593444029?lang=zh_cn&edition=full","pubTime":"2025-12-24 10:20","pubTimestamp":1766542801,"startTime":"0","endTime":"0","summary":"览富财经网讯：12月23日，据港交所网站披露，12月23日，Frontera Therapeutics - B递表港交所拟于港交所主板上市。据招股书披露，Frontera Therapeutics是一家处于临床阶段的基因治疗公司，专注于创 新疗法的研发，具有国际化业务布局，致力于为世界各地的患者提供安全、有效且可负担的基因治疗方案。自2019年成立以来，一直致力于自主开发创新的rAAV基因疗法。Frontera Therapeutics 目前没有任何产品获准商业销售，并于往绩记录期间录得亏损。","market":"sh","thumbnail":" http://caiji.3g.cnfol.com/colect/202512/24/20251224320488.jpg","type":0,"news_type":0,"thumbnails":[" http://caiji.3g.cnfol.com/colect/202512/24/20251224320488.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/ggzixun/20251224/31887833.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["HEXmain","BK4539","LENZ","BK4007","BK4139"],"gpt_icon":0},{"id":"2593175614","title":"Atossa Therapeutics, Inc.盘中异动 早盘股价大跌5.01%报0.681美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2593175614","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593175614?lang=zh_cn&edition=full","pubTime":"2025-12-23 23:58","pubTimestamp":1766505485,"startTime":"0","endTime":"0","summary":"北京时间2025年12月23日23时58分，Atossa Therapeutics, Inc.股票出现波动，股价快速下挫5.01%。截至发稿，该股报0.681美元/股，成交量62.8961万股，换手率0.49%，振幅4.35%。Atossa Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.07%。Atossa Therapeutics, Inc.公司简介：Atossa Therapeutics Inc 是一家临床阶段的生物制药公司，在肿瘤学领域未满足的医疗需求领域开发专有药物。该公司正在开发的用于治疗乳腺癌和其他乳腺疾病的药物是 Endoxifen。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025122323580597a09c2b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025122323580597a09c2b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ATOWW","LENZ","BK4539","BK4007","ATOS"],"gpt_icon":0},{"id":"2593419675","title":"【新股IPO】Frontera Therapeutics - B向港交所主板递交上市申请","url":"https://stock-news.laohu8.com/highlight/detail?id=2593419675","media":"金吾财讯","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593419675?lang=zh_cn&edition=full","pubTime":"2025-12-23 23:15","pubTimestamp":1766502959,"startTime":"0","endTime":"0","summary":"金吾财讯 | 据港交所12月23日披露，Frontera Therapeutics - B向港交所主板递交上市申请，瑞银集团、国泰海通为联席保荐人。公司是一家处于临床阶段的基因治疗公司，自2019年成立以来，公司一直致力于自主开发创新的重组腺相关病毒基因疗法。公司已开发出一条差异化且临床进展领先的管线，具全球同类最佳潜力，特别是针对眼科及心血管疾病。","market":"sg","thumbnail":"https://static.szfiu.com/news/20220324/ODFiZjIzMmMyMWE2ZjBhMTAzMDA1NjgwOTQz.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20220324/ODFiZjIzMmMyMWE2ZjBhMTAzMDA1NjgwOTQz.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1972127","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4007","BK4539","LENZ","HEXmain"],"gpt_icon":0},{"id":"2593343466","title":"Marker Therapeutics, Inc.盘中异动 早盘股价大涨5.47%报1.35美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2593343466","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593343466?lang=zh_cn&edition=full","pubTime":"2025-12-22 23:56","pubTimestamp":1766419011,"startTime":"0","endTime":"0","summary":"北京时间2025年12月22日23时56分，Marker Therapeutics, Inc.股票出现异动，股价快速拉升5.47%。截至发稿，该股报1.35美元/股，成交量11.3981万股，换手率0.68%，振幅4.69%。Marker Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.77%。Marker Therapeutics, Inc.公司简介：Marker Therapeutics Inc 是一家临床阶段的免疫肿瘤学公司，专门从事用于治疗血液系统恶性肿瘤和实体瘤适应症的新型基于 T 细胞的免疫疗法和基于肽的疫苗的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025122223565197a08eaf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025122223565197a08eaf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","LENZ","MRKR","BK4139","BK4539"],"gpt_icon":0},{"id":"2593439483","title":"Werewolf Therapeutics, Inc.盘中异动 大幅上涨7.73%报0.740美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2593439483","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593439483?lang=zh_cn&edition=full","pubTime":"2025-12-22 22:30","pubTimestamp":1766413837,"startTime":"0","endTime":"0","summary":"北京时间2025年12月22日22时30分，Werewolf Therapeutics, Inc.股票出现波动，股价急速上涨7.73%。Werewolf Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。其相关个股中，Psyence Biomedical Ltd C/Wts 25/01/2029、Equillium, Inc.、Quantum Biopharma Ltd.涨幅较大，Pmgc Holdings Inc.、Psyence Biomedical Ltd.、Gt Biopharma, Inc.较为活跃，换手率分别为111.15%、15.05%、7.44%，振幅较大的相关个股有Hcw Biologics Inc.、Novabay Pharmaceuticals, Inc.、Jupiter Neurosciences, Inc.，振幅分别为5.15%、4.97%、4.89%。Werewolf Therapeutics, Inc.公司简介：Werewolf Therapeutics Inc 是一家生物制药公司，致力于开创性地开发用于治疗癌症的、旨在刺激人体免疫系统的治疗药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025122222303797a08d67&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025122222303797a08d67&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","BK4539","BK4007","HOWL"],"gpt_icon":0},{"id":"2592194636","title":"Transcode Therapeutics, Inc.盘中异动 下午盘股价大涨5.29%报8.27美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2592194636","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592194636?lang=zh_cn&edition=full","pubTime":"2025-12-20 02:13","pubTimestamp":1766168008,"startTime":"0","endTime":"0","summary":"北京时间2025年12月20日02时13分，Transcode Therapeutics, Inc.股票出现波动，股价大幅上涨5.29%。Transcode Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.61%。Transcode Therapeutics, Inc.公司简介：TransCode Therapeutics Inc是一家生物制药公司，专注于开发和商业化用于癌症治疗和诊断的创新药物和诊断工具。TransCode最近启动了其首次临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251220021328953b7676&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251220021328953b7676&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","RNAZ","BK4539","BK4007"],"gpt_icon":0},{"id":"2592184118","title":"Dogwood Therapeutics, Inc.盘中异动 快速跳水5.32%","url":"https://stock-news.laohu8.com/highlight/detail?id=2592184118","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592184118?lang=zh_cn&edition=full","pubTime":"2025-12-19 04:07","pubTimestamp":1766088444,"startTime":"0","endTime":"0","summary":"北京时间2025年12月19日04时07分，Dogwood Therapeutics, Inc.股票出现波动，股价快速下跌5.32%。Dogwood Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.67%。其相关个股中，Protagenic Therapeutics Inc C/Wts 26/04/2026 、Athira Pharma, Inc.、Greenwich Lifesciences, Inc.涨幅较大，Athira Pharma, Inc.、Biodexa Pharmaceuticals Plc、Aditxt, Inc.较为活跃，换手率分别为1483.15%、291.20%、113.88%，振幅较大的相关个股有Protagenic Therapeutics Inc C/Wts 26/04/2026 、健永生技、Lexaria Bioscience Corp C/Wts 14/01/2026 ，振幅分别为65.12%、45.85%、44.39%。Dogwood Therapeutics, Inc.公司简介：Dogwood Therapeutics Inc前身为Virios Therapeutics Inc，是一家处于开发阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251219040724953b6d41&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251219040724953b6d41&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4007","DWTX","LENZ","BK4539"],"gpt_icon":0},{"id":"2592184160","title":"Context Therapeutics Inc.盘中异动 早盘股价大涨5.36%报1.18美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2592184160","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592184160?lang=zh_cn&edition=full","pubTime":"2025-12-19 00:12","pubTimestamp":1766074322,"startTime":"0","endTime":"0","summary":"北京时间2025年12月19日00时12分，Context Therapeutics Inc.股票出现波动，股价快速拉升5.36%。截至发稿，该股报1.18美元/股，成交量48.0489万股，换手率0.52%，振幅3.13%。Context Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为0.27%。Context Therapeutics Inc.公司简介：Context Therapeutics Inc是一家处于临床阶段的生物制药公司，致力于推进针对实体肿瘤的药物开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251219001202a45c42a8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251219001202a45c42a8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","CNTX","BK4539","BK4007"],"gpt_icon":0},{"id":"2592797530","title":"Briacell Therapeutics Corp C/Wts 26/02/2026(To Pur Com)盘中异动 早盘大幅下跌10.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2592797530","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592797530?lang=zh_cn&edition=full","pubTime":"2025-12-18 00:06","pubTimestamp":1765987598,"startTime":"0","endTime":"0","summary":"北京时间2025年12月18日00时06分，Briacell Therapeutics Corp C/Wts 26/02/2026股票出现波动，股价大幅跳水10.26%。Briacell Therapeutics Corp C/Wts 26/02/2026股票所在的生物技术行业中，整体涨幅为0.30%。Briacell Therapeutics Corp C/Wts 26/02/2026公司简介：BriaCell Therapeutics Corp是一家临床阶段的生物技术公司，专注于开发用于癌症治疗的免疫疗法。BriaCell参与临床合作，探索联合疗法，以增强癌症治疗方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251218000638a457a5d3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251218000638a457a5d3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4539","BCTXW","BK4139","BK4007"],"gpt_icon":0},{"id":"2592945080","title":"Alaunos Therapeutics, Inc.盘中异动 股价大跌6.65%报4.07美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2592945080","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592945080?lang=zh_cn&edition=full","pubTime":"2025-12-17 23:50","pubTimestamp":1765986645,"startTime":"0","endTime":"0","summary":"北京时间2025年12月17日23时50分，Alaunos Therapeutics, Inc.股票出现异动，股价快速下挫6.65%。Alaunos Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.17%。Alaunos Therapeutics, Inc.公司简介：Alaunos Therapeutics Inc 是一家处于临床前阶段的肥胖和代谢健康药物开发公司，致力于开发一种基于小分子的药物，用于治疗肥胖和其他代谢紊乱，其特性与目前已上市和正在开发的口服和注射产品有所不同。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251217235045a4579946&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251217235045a4579946&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4007","BK4139","BK4539","TCRT"],"gpt_icon":0},{"id":"2592108819","title":"Monte Rosa Therapeutics, Inc.盘中异动 大幅下跌5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2592108819","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592108819?lang=zh_cn&edition=full","pubTime":"2025-12-17 22:55","pubTimestamp":1765983331,"startTime":"0","endTime":"0","summary":"北京时间2025年12月17日22时55分，Monte Rosa Therapeutics, Inc.股票出现波动，股价快速下跌5.04%。Monte Rosa Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.19%。Monte Rosa Therapeutics, Inc.公司简介：Monte Rosa Therapeutics Inc是一家生物技术公司，专门开发分子胶降解剂，这是一类利用人体天然蛋白质破坏机制选择性降解治疗相关蛋白质的小分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251217225531a457725a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251217225531a457725a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4007","GLUE","BK4139","LENZ"],"gpt_icon":0},{"id":"2592945088","title":"Prelude Therapeutics Incorporated盘中异动 早盘股价大涨5.03%报2.09美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2592945088","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592945088?lang=zh_cn&edition=full","pubTime":"2025-12-17 22:41","pubTimestamp":1765982476,"startTime":"0","endTime":"0","summary":"北京时间2025年12月17日22时41分，Prelude Therapeutics Incorporated股票出现异动，股价快速上涨5.03%。截至发稿，该股报2.09美元/股，成交量6.5578万股，换手率0.10%，振幅3.52%。Prelude Therapeutics Incorporated股票所在的生物技术行业中，整体涨幅为0.28%。Prelude Therapeutics Incorporated公司简介：Prelude Therapeutics Incorp是一家临床阶段的精准肿瘤学公司，专注于发现和开发针对癌症关键驱动机制的小分子疗法，以满足高度未满足需求的癌症治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025121722411697a06ea9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025121722411697a06ea9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","PRLD","BK4539","LENZ","BK4139","BK4505"],"gpt_icon":0},{"id":"2592912681","title":"Vistagen Therapeutics, Inc.股价重挫78.99% 市值跌2857.38万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2592912681","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592912681?lang=zh_cn&edition=full","pubTime":"2025-12-17 22:31","pubTimestamp":1765981882,"startTime":"0","endTime":"0","summary":"北京时间2025年12月17日22时31分，Vistagen Therapeutics, Inc.股票出现异动，股价急速下挫78.99%。截至发稿，该股报0.916美元/股，成交量885.289万股，换手率22.41%，振幅1.12%。Vistagen Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.27%。其相关个股中，Protagenic Therapeutics Inc C/Wts 26/04/2026 、Vyne Therapeutics Inc.、Aditxt, Inc.涨幅较大，Pmgc Holdings Inc.、Aditxt, Inc.、Vyne Therapeutics Inc.较为活跃，换手率分别为1009.00%、827.45%、236.84%，振幅较大的相关个股有Vyne Therapeutics Inc.、Mindwalk Holdings Corp.、Rezolute, Inc.，振幅分别为12.17%、11.31%、10.89%。Vistagen Therapeutics, Inc.公司简介：VistaGen Therapeutics Inc是一家生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251217223122a6ae7069&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251217223122a6ae7069&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","VTGN","BK4139","LENZ","BK4007"],"gpt_icon":1},{"id":"1187647177","title":"Lenz Therapeutics - 不良事件报告系统数据库描述使用Vizz（Aceclidine眼用溶液）患者视网膜撕裂的案例","url":"https://stock-news.laohu8.com/highlight/detail?id=1187647177","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1187647177?lang=zh_cn&edition=full","pubTime":"2025-12-13 05:28","pubTimestamp":1765574895,"startTime":"0","endTime":"0","summary":"Lenz Therapeutics - 不良事件报告系统数据库描述使用Vizz（Aceclidine眼用溶液）患者视网膜撕裂的案例","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","LENZ","BK4139","BK4539"],"gpt_icon":0},{"id":"2588848057","title":"Edgewise Therapeutics, Inc.盘中异动 早盘大幅下挫5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2588848057","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588848057?lang=zh_cn&edition=full","pubTime":"2025-12-03 00:17","pubTimestamp":1764692235,"startTime":"0","endTime":"0","summary":"北京时间2025年12月03日00时17分，Edgewise Therapeutics, Inc.股票出现波动，股价大幅下跌5.05%。Edgewise Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.03%。其相关个股中，Polyrizon Ltd.、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025、Ethzilla Corporation涨幅较大，Polyrizon Ltd.、Clearmind Medicine Inc.、Jasper Therapeutics, Inc.较为活跃，换手率分别为8412.37%、323.17%、185.84%，振幅较大的相关个股有Polyrizon Ltd.、Akari Therapeutics Plc、Sonnet Biotherapeutics Holdings, Inc.，振幅分别为79.43%、70.43%、50.65%。Edgewise Therapeutics, Inc.公司简介：Edgewise Therapeutics Inc是一家临床阶段的生物制药公司。该公司的候选产品是Sevasemten和EDG-7500。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025120300171595270e55&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025120300171595270e55&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4007","LENZ","EWTX","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://ir.graphitebio.com","stockEarnings":[{"period":"1week","weight":-0.0628},{"period":"1month","weight":-0.4508},{"period":"3month","weight":-0.5986},{"period":"6month","weight":-0.441},{"period":"1year","weight":-0.473},{"period":"ytd","weight":-0.4157}],"compareEarnings":[{"period":"1week","weight":0.0143},{"period":"1month","weight":0.0156},{"period":"3month","weight":0.043},{"period":"6month","weight":0.1226},{"period":"1year","weight":0.148},{"period":"ytd","weight":0.1778}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"LENZ Therapeutics, Inc.于2017年6月1日加拿大安大略省注册成立，并于2019年10月在特拉华州重新注册。他们是一家临床阶段的下一代基因编辑公司，利用高效靶向基因整合开发新型疗法有可能治愈范围广泛的严重和危及生命的疾病。他们正在开创一种精确的基因编辑方法，以实现医学上最难以实现的目标之一：精确“找到并替换”基因组中的任何基因。他们的下一代基因编辑平台使他们能够精确地纠正突变，用正常基因替换整个致病基因，或将新基因插入预定的安全位置。","yearOnYearQuotes":[{"month":1,"riseRate":0.25,"avgChangeRate":-0.169631},{"month":2,"riseRate":0.5,"avgChangeRate":0.077415},{"month":3,"riseRate":0.25,"avgChangeRate":-0.098838},{"month":4,"riseRate":0.5,"avgChangeRate":-0.02248},{"month":5,"riseRate":0.25,"avgChangeRate":-0.134416},{"month":6,"riseRate":0.75,"avgChangeRate":0.05507},{"month":7,"riseRate":0.6,"avgChangeRate":0.05308},{"month":8,"riseRate":0.4,"avgChangeRate":0.016536},{"month":9,"riseRate":0.6,"avgChangeRate":0.026875},{"month":10,"riseRate":0.6,"avgChangeRate":-0.067546},{"month":11,"riseRate":0.6,"avgChangeRate":-0.005451},{"month":12,"riseRate":0.4,"avgChangeRate":-0.03271}],"exchange":"NASDAQ","name":"Therapeutics","nameEN":"Therapeutics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.13","shortVersion":"4.35.13","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Therapeutics(LENZ)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Therapeutics(LENZ)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Therapeutics,LENZ,Therapeutics股票,Therapeutics股票老虎,Therapeutics股票老虎国际,Therapeutics行情,Therapeutics股票行情,Therapeutics股价,Therapeutics股市,Therapeutics股票价格,Therapeutics股票交易,Therapeutics股票购买,Therapeutics股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Therapeutics(LENZ)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Therapeutics(LENZ)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}